Dual inhibition of MAGL and type II topoisomerase by N-phenylmaleimides as a potential strategy to reduce neuroblastoma cell growth.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Pharmaceutical Sciences

• Publication date

  2012-02-14

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ejps.2011.11.011PMID 22127371
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Monoacylglycerol lipase (MAGL) knockdown inhibits tumor cells growth in colorectal cancer.

  2011cited by this paper
• A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma

  2011cited by this paper
• Cannabinoids attenuate cancer pain and proliferation in a mouse model.

  2011cited by this paper
• Anti-proliferative effect of a putative endocannabinoid, 2-arachidonylglyceryl ether in prostate carcinoma cells.

  2011influential reference
• Design and synthesis of novel camptothecin/5-fluorouracil conjugates as cytotoxic agents

  2011cited by this paper
• Increasing Antiproliferative Properties of Endocannabinoids in N1E-115 Neuroblastoma Cells through Inhibition of Their Metabolism

  2011cited by this paper
• Antiproliferative mechanism of a cannabinoid agonist by cell cycle arrest in human gastric cancer cells

  2011cited by this paper
• Monoacylglycerol Lipase Activity Is a Critical Modulator of the Tone and Integrity of the Endocannabinoid System

  2010cited by this paper
• The endocannabinoid 2-arachidonoylglycerol (2-AG) and metabolizing enzymes during rat fetoplacental development: a role in uterine remodelling.

  2010cited by this paper
• Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis.

  2010cited by this paper
• Antagonism of Cytotoxic Chemotherapy in Neuroblastoma Cell Lines by 13-cis-Retinoic Acid Is Mediated by the Antiapoptotic Bcl-2 Family Proteins

  2010cited by this paper
• Synthesis of 3-fluoro-6-S-(2-S-pyridyl) nucleosides as potential lead cytostatic agents

  2010cited by this paper
• Inhibition of DNA topoisomerases I and II and cytotoxicity of compounds from Ulmus davidiana var. japonica

  2010cited by this paper
• Neuronal models for evaluation of proliferation in vitro using high content screening.

  2010cited by this paper
• Endocannabinoid biosynthesis and inactivation, from simple to complex.

  2010cited by this paper
• Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon

  2009cited by this paper
• Characterization of the Endocannabinoid System in Human Neuronal Cells and Proteomic Analysis of Anandamide-induced Apoptosis*

  2009cited by this paper
• Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors.

  2009cited by this paper
• Protection against amyloid beta cytotoxicity by sulforaphane: Role of the proteasome

  2009cited by this paper
• Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects

  2008influential reference
• The Nitrone Disodium 2,4-Sulphophenyl-N-Tert-Butylnitrone is Without Cytoprotective Effect on Sodium Nitroprusside-Induced Cell Death in N1E-115 Neuroblastoma Cells in vitro

  2008cited by this paper
• CAY10499, a Novel Monoglyceride Lipase Inhibitor Evidenced by an Expeditious MGL Assay

  2008cited by this paper
• Reciprocal influences of CB1 cannabinoid receptor agonists on ERK and JNK signalling in N1E‐115 cells

  2008cited by this paper
• The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species

  2007cited by this paper
• Agonist selective modulation of tyrosine hydroxylase expression by cannabinoid ligands in a murine neuroblastoma cell line

  2007cited by this paper
• Opposing Actions of Endocannabinoids on Cholangiocarcinoma Growth

  2007influential reference
• The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

  2007cited by this paper
• Diverse roles of 2‐arachidonoylglycerol in invasion of prostate carcinoma cells: Location, hydrolysis and 12‐lipoxygenase metabolism

  2007cited by this paper
• Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel‐induced cancer cell death both in vitro and in vivo

  2006cited by this paper
• Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes.

  2005cited by this paper
• A new strategy to block tumor growth by inhibiting endocannabinoid inactivation

  2004cited by this paper
• Possible endocannabinoid control of colorectal cancer growth.

  2003cited by this paper
• Rationally designed hydrolytically activated etoposide prodrugs, a novel strategy for the treatment of neuroblastoma.

  2003cited by this paper
• Topoisomerase II inhibitors.

  2003cited by this paper
• Anti‐proliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: Implication of epidermal growth factor receptor down‐regulation and ceramide production

  2003cited by this paper
• Inhibition of C6 glioma cell proliferation by anandamide, 1-arachidonoylglycerol, and by a water soluble phosphate ester of anandamide: variability in response and involvement of arachidonic acid.

  2003cited by this paper
• Maleimide is a potent inhibitor of topoisomerase II in vitro and in vivo: a new mode of catalytic inhibition.

  2002influential reference
• Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors.

  2001influential reference
• DNA topoisomerases as anticancer drug targets: from the laboratory to the clinic.

  2001cited by this paper
• DNA relaxation and cleavage assays to study topoisomerase I inhibitors.

  2001cited by this paper
• Cannabimimetic fatty acid derivatives in cancer and inflammation.

  2000cited by this paper
• Anandamide Induces Apoptosis in Human Cells via Vanilloid Receptors

  2000cited by this paper
• Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders.

  2000cited by this paper
• Yeast Topoisomerase II Is Inhibited by Etoposide After Hydrolyzing the First ATP and Before Releasing the Second ADP*

  1999cited by this paper
• Etoposide: four decades of development of a topoisomerase II inhibitor.

  1998cited by this paper
• Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase.

  1997cited by this paper
• Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

  1997cited by this paper
• Mapping of DNA topoisomerase II poisons (etoposide, clerocidin) and catalytic inhibitors (aclarubicin, ICRF-187) to four distinct steps in the topoisomerase II catalytic cycle.

  1996cited by this paper
• Antitumor agents. 3. Synthesis and biological activity of 4 beta-alkyl derivatives containing hydroxy, amino, and amido groups of 4'-O-demethyl-4-desoxypodophyllotoxin as antitumor agents.

  1993cited by this paper
• Inhibition of topoisomerase II by antitumor agents bis(2,6-dioxopiperazine) derivatives.

  1991cited by this paper
• The effects of single dose oral hydralazine on blood flow through human lung tumours.

  1990cited by this paper
• Themed Issue: Cannabinoids in Biology and Medicine, Part I the Endocannabinoid System and Cancer: Therapeutic Implication Received Revised Linked Articles

  year unknowncited by this paper

• Cyclic Imides as Bioactive Scaffolds for Various Neurological Disorders (A Review)

  2025cites this paper
• Adipose triglyceride lipase promotes the proliferation of colorectal cancer cells via enhancing the lipolytic pathway

  2021cites this paper
• The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies

  2021cites this paper
• Decreased serum levels of glycerol-3- phosphate dehydrogenase 1 and monoacylglycerol lipase act as diagnostic biomarkers for breast cancer

  2021cites this paper
• The Monoacylglycerol Lipase Inhibitor JZL184 Inhibits Lung Cancer Cell Invasion and Metastasis via the CB1 Cannabinoid Receptor

  2021cites this paper
• On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence

  2021cites this paper
• Enhanced monoacylglycerol lipolysis by ABHD6 promotes NSCLC pathogenesis

  2020cites this paper
• Comparative Proteome Analysis of Breast Cancer Tissues Highlights the Importance of Glycerol-3-phosphate Dehydrogenase 1 and Monoacylglycerol Lipase in Breast Cancer Metabolism

  2019cites this paper
• Development, Optimization, and Validation of a High Throughput Screening Assay for Identification of Tat and Type II Secretion Inhibitors of Pseudomonas aeruginosa

  2019cites this paper
• Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer

  2019cites this paper
• Enhanced Monoacylglycerol Lipolysis by ABHD6 Promotes NSCLC Pathophysiology

  2019cites this paper
• Monoglyceride lipase as a drug target: At the crossroads of arachidonic acid metabolism and endocannabinoid signaling

  2017cites this paper
• Monoacylglycerol Lipase: A Novel Potential Therapeutic Target and Prognostic Indicator for Hepatocellular Carcinoma

  2016cites this paper
• A magnetic nanogel based on O-carboxymethylchitosan for antitumor drug delivery: synthesis, characterization and in vitro drug release.

  2014cites this paper
• Molecular docking and QSAR analysis on maleimide derivatives selective inhibition against human monoglyceride lipase based on various modeling methods and conformations

  2014cites this paper
• Electrochemically Reduced Water Protects Neural Cells from Oxidative Damage

  2014cites this paper
• Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.

  2012cites this paper